PRISMATIC AI
DEAD

Serial Number

97524409

Owner

Zephyr AI, Inc.

Attorney

Jamie E. Sternberg

Filing Date

Jul 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PRISMATIC AI Trademark

Serial Number: 97524409

PRISMATIC AI is a trademark filed by Zephyr AI, Inc. on July 28, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Zephyr AI, Inc. (4 trademarks)

3889 Maple Avenue, Suite 500
Dallas, TX 75219

Entity Type: 03

Trademark Details

Filing Date

July 28, 2022

Registration Date

Not Registered

Published for Opposition

August 29, 2023

Goods & Services

Downloadable computer programs using artificial intelligence for machine learning; downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer software, downloadable computer software platforms, downloadable mobile applications, and downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer programs using artificial intelligence for machine learning in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals

Scientific research consulting services in the field of genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; scientific research consulting; scientific services, namely, analysis of scientific and clinical data in the fields of genetic, biologic, oncological and diabetes-related data; genetic and tumor mapping for scientific and medical purposes; providing scientific research information in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; drug discovery services; pharmaceutical services, namely, providing an online searchable database in the fields of genetics, oncology, and diabetes for scientific research purposes and treatment and diagnostic purposes; scientific research services, namely, analyzing genetic, oncological, biological and diabetes-related data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing scientific and clinical research and scientific consulting services by using machine learning and artificial intelligence technology in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; scientific research and consulting, namely, designing and supporting clinical trials for others; scientific research and development services in the collection of information and data on biologicals for research purposes; providing on-line searchable genetic reference databases being collections of gene sequences for scientific research purposes; scientific research services, namely, disease modeling for research purposes; scientific analysis services, namely, services using computer algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer, diabetes, and other diseases; pharmaceutical drug development services; scientific research in the field of biomarker rankings; scientific research and development of pharmaceutical preparations; consulting services in the field of pharmaceutical research and development; providing temporary use of online non-downloadable software and software platforms featuring artificial intelligence and machine learning technologies for scientific research and development in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; providing a web site featuring temporary use of non-downloadable software featuring artificial intelligence and machine learning technologies for scientific research and development in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; software design and development; computer software installation and maintenance; DNA analysis services for scientific research purposes; application service provider (ASP) featuring software using artificial intelligence for machine learning

Filing History

ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Mar 21, 2024 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Mar 21, 2024 ABN4
OPPOSITION TERMINATED NO. 999999
Mar 21, 2024 OP.T
OPPOSITION SUSTAINED NO. 999999
Mar 21, 2024 OP.S
OPPOSITION INSTITUTED NO. 999999
Dec 21, 2023 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 20, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 29, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 29, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 9, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 30, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 6, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 5, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2022 NWOS
NEW APPLICATION ENTERED
Aug 1, 2022 NWAP